Maternal colonization with extended‐spectrum β‐lactamase‐producing Enterobacteriaceae in term versus preterm pregnancies

To examine the prevalence and risk factors of extended‐spectrum β‐lactamase‐producing Enterobacteriaceae (ESBL‐E) colonization among women who delivered preterm and at term.

[1]  T. Velavan,et al.  Maternal Vaginal Colonization and Extended-Spectrum Beta-Lactamase-Producing Bacteria in Vietnamese Pregnant Women , 2021, Antibiotics.

[2]  J. Bornstein,et al.  Vertical Transmission of Extended-Spectrum, Beta-Lactamase-Producing Enterobacteriaceae during Preterm Delivery: A Prospective Study , 2021, Microorganisms.

[3]  J. Bornstein,et al.  A novel, extended prophylactic antibiotic regimen in preterm pre-labor rupture of membranes: a randomized trial. , 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[4]  E. Presterl,et al.  Vaginal colonization of extended-spectrum beta-lactamase-producing bacteria during pregnancy: An observational study. , 2020, European journal of obstetrics, gynecology, and reproductive biology.

[5]  J. Meza,et al.  Neonatal outcomes associated with maternal recto-vaginal colonization with extended-spectrum beta-lactamase producing Enterobacteriaceae in Nigeria; a prospective, cross-sectional study. , 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[6]  A. Glatman-Freedman,et al.  Nationwide epidemiology of early‐onset sepsis in Israel 2010‐2015, time to re‐evaluate empiric treatment , 2019, Acta paediatrica.

[7]  N. Silverman,et al.  ACOG Practice Bulletin No. 199: Use of Prophylactic Antibiotics in Labor and Delivery. , 2018, Obstetrics and gynecology.

[8]  T. Chakraborty,et al.  Predictors of the extended-spectrum-beta lactamases producing Enterobacteriaceae neonatal sepsis at a tertiary hospital, Tanzania , 2018, International journal of medical microbiology : IJMM.

[9]  P. Mathur,et al.  Alarming rates of antimicrobial resistance and fungal sepsis in outborn neonates in North India , 2018, PloS one.

[10]  D. Yusef,et al.  Clinical characteristics and epidemiology of sepsis in the neonatal intensive care unit in the era of multi-drug resistant organisms: A retrospective review. , 2017, Pediatrics and neonatology.

[11]  S. Madhi,et al.  Preterm Birth Associated With Group B Streptococcus Maternal Colonization Worldwide: Systematic Review and Meta-analyses , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  S. Mehtar,et al.  Maternal colonization or infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae in Africa: A systematic review and meta-analysis. , 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[13]  Lakshmi Rajagopal,et al.  Bacterial Hyaluronidase Promotes Ascending GBS Infection and Preterm Birth , 2016, mBio.

[14]  P. Savelkoul,et al.  Prevalence and risk factors for carriage of ESBL-producing Enterobacteriaceae in Amsterdam , 2016, The Journal of antimicrobial chemotherapy.

[15]  P. Gastmeier,et al.  The mother as most important risk factor for colonization of very low birth weight (VLBW) infants with extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E). , 2014, The Journal of antimicrobial chemotherapy.

[16]  Chiang-Wen Lee,et al.  Risk Factors and Outcomes for Multidrug-Resistant Gram-Negative Bacteremia in the NICU , 2014, Pediatrics.

[17]  H. Villar,et al.  Maternal carriage of extended-spectrum beta-lactamase-producing Escherichia coli isolates in Argentina , 2013, Journal of chemotherapy.

[18]  Sareaa Mg Al-Mayahie.  Phenotypic and genotypic comparison of ESBL production by Vaginal Escherichia coli isolates from pregnant and non-pregnant women , 2013, Annals of Clinical Microbiology and Antimicrobials.

[19]  F. Kironde,et al.  Uropathogenic Escherichia coli Isolates from Pregnant Women in Different Countries , 2012, Journal of Clinical Microbiology.

[20]  G. Thurnau,et al.  Antibiotic Therapy for Reduction of Infant Morbidity After Preterm Premature Rupture of the Membranes: A Randomized Controlled Trial , 1997 .

[21]  G. Thurnau,et al.  Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. , 1997, JAMA.

[22]  N. Kiviat,et al.  Microbiologic causes and neonatal outcomes associated with chorioamnion infection. , 1991, American journal of obstetrics and gynecology.